Journal articles on the topic 'Extrapyramidales System'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Extrapyramidales System.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
de Oliveira-Souza, Ricardo. "The human extrapyramidal system." Medical Hypotheses 79, no. 6 (2012): 843–52. http://dx.doi.org/10.1016/j.mehy.2012.09.004.
Full textSano, H. "Biochemistry of the extrapyramidal system." Parkinsonism & Related Disorders 6, no. 1 (2000): 3–6. http://dx.doi.org/10.1016/s1353-8020(99)00046-2.
Full textBarbanti, P., and G. Fabbrini. "Migraine and the Extrapyramidal System." Cephalalgia 22, no. 1 (2002): 2–11. http://dx.doi.org/10.1046/j.1468-2982.2002.00313.x.
Full text&NA;, &NA;. "Neuropharmacology of the extrapyramidal system." Pain 35, no. 2 (1988): 219. http://dx.doi.org/10.1016/0304-3959(88)90244-8.
Full textKirkpatrick, Brian, and Carol A. Tamminga. "The Endocrinology of Extrapyramidal System Disorders." Endocrinology and Metabolism Clinics of North America 17, no. 1 (1988): 159–72. http://dx.doi.org/10.1016/s0889-8529(18)30439-0.
Full textKirkpatrick, Brian, and Carol A. Tamminga. "The Endocrinology of Extrapyramidal System Disorders." Neurologic Clinics 6, no. 1 (1988): 159–72. http://dx.doi.org/10.1016/s0733-8619(18)30890-9.
Full textRosse, Richard B., and Jon Peters. "Depression Dependent Parkinsonism: Case Report." International Journal of Psychiatry in Medicine 16, no. 1 (1987): 85–90. http://dx.doi.org/10.2190/ghrn-7rwe-lpd8-rfp7.
Full textArya, Dinesh K. "Extrapyramidal Symptoms with Selective Serotonin Reuptake Inhibitors." British Journal of Psychiatry 165, no. 6 (1994): 728–33. http://dx.doi.org/10.1192/bjp.165.6.728.
Full textDrobný, Michal, and Egon Kurča. "Possible extrapyramidal system degradation in Parkinson’s disease." Brain Research Bulletin 53, no. 4 (2000): 425–30. http://dx.doi.org/10.1016/s0361-9230(00)00367-1.
Full textde Oliveira-Souza, Ricardo, and Fernanda Tovar-Moll. "The Unbearable Lightness of the Extrapyramidal System." Journal of the History of the Neurosciences 21, no. 3 (2012): 280–92. http://dx.doi.org/10.1080/0964704x.2011.595652.
Full textHasegawa, Kazuko, Hisayuki Kowa, and Saburo Yagishita. "Extrapyramidal system involvement in motor neuron disease." Journal of the Neurological Sciences 108, no. 2 (1992): 137–48. http://dx.doi.org/10.1016/0022-510x(92)90044-l.
Full textKudrevatykh, Anastasiya V., and Irina V. Miliukhina. "Diagnostic capabilities of posturological methods in extrapyramidal disorders." Medical academic journal 20, no. 1 (2020): 45–50. http://dx.doi.org/10.17816/maj26249.
Full textGirling, D. M., and G. E. Berrios. "Extrapyramidal Signs, Primitive Reflexes and Frontal Lobe Function in Senile Dementia of the Alzheimer Type." British Journal of Psychiatry 157, no. 6 (1990): 888–93. http://dx.doi.org/10.1192/bjp.157.6.888.
Full textOczkowska, Anna, Wojciech Kozubski, Margarita Lianeri, and Jolanta Dorszewska. "Genetic Variants in Diseases of the Extrapyramidal System." Current Genomics 15, no. 1 (2014): 18–27. http://dx.doi.org/10.2174/1389202914666131210213327.
Full textMeara, R. J. "Serotonin and the extrapyramidal system — A neurological perspective." European Psychiatry 11 (January 1996): 254s. http://dx.doi.org/10.1016/0924-9338(96)88765-7.
Full textMeara, Jolyon. "Serotonin and the extrapyramidal system ? a neurological perspective." Human Psychopharmacology: Clinical and Experimental 11, S2 (1996): S95—S102. http://dx.doi.org/10.1002/(sici)1099-1077(199606)11:2+
Senanayake, N., and PS Sanmuganathan. "Extrapyramidal manifestations complicating organophosphorus insecticide poisoning." Human & Experimental Toxicology 14, no. 7 (1995): 600–604. http://dx.doi.org/10.1177/096032719501400708.
Full textZalyalova, Z. A., E. I. Bogdanov, G. R. Latypova, and L. A. Yakovleva. "Clinical-epidemiological aspects of Kazan Center for Extrapyramidal Pathology." Bulletin of Siberian Medicine 7, no. 5-1 (2008): 150–55. http://dx.doi.org/10.20538/1682-0363-2008-5-1-150-155.
Full textOliveira-Souza, R. "Motor hemiplegia and the cerebral organization of movement in man: II. The myth of the human extrapyramidal system." Arquivos de Neuro-Psiquiatria 47, no. 1 (1989): 16–27. http://dx.doi.org/10.1590/s0004-282x1989000100003.
Full textNeuhäuser, G. "Degenerative Erkrankungen des extrapyramidalen und des spinozerebellären Systems - Differentialdiagnostische Hinweise*." Klinische Pädiatrie 198, no. 02 (1986): 89–95. http://dx.doi.org/10.1055/s-2008-1026860.
Full textFilloux, Francis M. "Neuropathophysiology of Movement Disorders in Cerebral Palsy." Journal of Child Neurology 11, no. 1_suppl (1996): S5—S12. http://dx.doi.org/10.1177/0883073896011001s02.
Full textLoonen, Anton J. M., and Svetlana A. Ivanova. "Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD." Pharmacopsychiatry 52, no. 04 (2019): 203–4. http://dx.doi.org/10.1055/a-0835-6447.
Full textKulkarni, Gajanan P., and Lokesh V. Patil. "ANALYSIS OF ADVERSE DRUG REACTIONS SPONTANEOUSLY REPORTED TO ADVERSE DRUG MONITORING CENTRE OF A TERTIARY CARE HOSPITAL–PROSPECTIVE STUDY." International Journal of Current Pharmaceutical Research 10, no. 1 (2018): 23. http://dx.doi.org/10.22159/ijcpr.2018v10i1.24403.
Full textOhno, Yukihiro, Saki Shimizu, and Kentaro Tokudome. "Pathophysiological Roles of Serotonergic System in Regulating Extrapyramidal Motor Functions." Biological and Pharmaceutical Bulletin 36, no. 9 (2013): 1396–400. http://dx.doi.org/10.1248/bpb.b13-00310.
Full textGoto, S., Y. Matsukado, Y. Mihara, N. Inoue, and E. Miyamoto. "Calcineurin in human brain and its relation to extrapyramidal system." Acta Neuropathologica 72, no. 2 (1986): 150–56. http://dx.doi.org/10.1007/bf00685977.
Full textClementi, G., M. Grassi, C. Valerio, A. Prato, C. E. Fiore, and F. Drago. "Effects of calcitonin gene-related peptide on extrapyramidal motor system." Pharmacology Biochemistry and Behavior 42, no. 3 (1992): 545–48. http://dx.doi.org/10.1016/0091-3057(92)90153-7.
Full textNesic, Nada, Marina Svetel, Tatjana Pekmezovic, Ksenija Ribaric, Natasa Dragasevic, and Vladimir Kostic. "Clinical characteristics of multiple system atrophy in Serbian population." Vojnosanitetski pregled 63, no. 10 (2006): 861–66. http://dx.doi.org/10.2298/vsp0610861n.
Full textMajor, Zoltán Zsigmond, Calin Vaida, Kinga Andrea Major, et al. "The Impact of Robotic Rehabilitation on the Motor System in Neurological Diseases. A Multimodal Neurophysiological Approach." International Journal of Environmental Research and Public Health 17, no. 18 (2020): 6557. http://dx.doi.org/10.3390/ijerph17186557.
Full textVaiman, E. E., N. A. Shnayder, N. G. Neznanov, and R. F. Nasyrova. "Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia." Neurology, Neuropsychiatry, Psychosomatics 11, no. 4 (2019): 4–13. http://dx.doi.org/10.14412/2074-2711-2019-4-4-13.
Full textSandroni, Paola, J. Eric Ahlskog, Robert D. Fealey, and Phillip A. Low. "Autonomic involvement in extrapyramidal and cerebellar disorders." Clinical Autonomic Research 1, no. 2 (1991): 147–55. http://dx.doi.org/10.1007/bf01826212.
Full textAntkiewicz-Michaluk, Lucyna, Anna Krygowska-Wajs, Jerzy Michaluk, Irena Roma?ska, Andrzej Szczudlik, and Jerzy Vetulani. "Plasticity of extrapyramidal dopamine system in Parkinson's disease - A postmortem study." Neuroscience Research Communications 25, no. 2 (1999): 97–109. http://dx.doi.org/10.1002/(sici)1520-6769(199909/10)25:2<97::aid-nrc5>3.0.co;2-k.
Full textBRANDT, SVEN. "THE CLINICAL MANIFESTATION OF LESIONS TO THE EXTRAPYRAMIDAL SYSTEM IN CHILDREN." Acta Neurologica Scandinavica 39, S4 (2009): 158–68. http://dx.doi.org/10.1111/j.1600-0404.1963.tb01827.x.
Full textHanson, Glen R., Leonora P. Midgley, Lloyd G. Bush, and James W. Gibb. "Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment." European Journal of Pharmacology 278, no. 2 (1995): 167–73. http://dx.doi.org/10.1016/0014-2999(95)00127-7.
Full textMATOBA, Togo, Kazunori HASE, Yuichiro HAYASHI, and SungHyek KIM. "OS1406 Neuro-musculo-skeletal model considering extrapyramidal system for evaluation of spasticity." Proceedings of Conference of Kanto Branch 2016.22 (2016): _OS1406–1_—_OS1406–2_. http://dx.doi.org/10.1299/jsmekanto.2016.22._os1406-1_.
Full textSamanta, M. K., R. Dube, and B. Suresh. "Transdermal Drug Delivery System of Haloperidol to Overcome Self-Induced Extrapyramidal Syndrome." Drug Development and Industrial Pharmacy 29, no. 4 (2003): 405–15. http://dx.doi.org/10.1081/ddc-120018376.
Full textLoonen, Anton JM, and Svetlana A. Ivanova. "Neurobiological mechanisms associated with antipsychotic drug-induced dystonia." Journal of Psychopharmacology 35, no. 1 (2020): 3–14. http://dx.doi.org/10.1177/0269881120944156.
Full textHANSON, GLEN R., NANDA SINGH, KALPANA MERCHANT, MICHEL JOHNSON, LLOYD BUSH, and JAMES W. GIBB. "Responses of Limbic and Extrapyramidal Neurotensin Systems to Stimulants of Abuse." Annals of the New York Academy of Sciences 668, no. 1 The Neurobiol (1992): 165–72. http://dx.doi.org/10.1111/j.1749-6632.1992.tb27348.x.
Full textAlburges, Mario E., Paul S. Frankel, Amanda J. Hoonakker, and Glen R. Hanson. "Responses of limbic and extrapyramidal substance P systems to nicotine treatment." Psychopharmacology 201, no. 4 (2008): 517–27. http://dx.doi.org/10.1007/s00213-008-1316-3.
Full textGrubor, Mirko, Maja Zivkovic, Marina Sagud, et al. "HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia." International Journal of Molecular Sciences 21, no. 7 (2020): 2345. http://dx.doi.org/10.3390/ijms21072345.
Full textOrsini, A., N. A. Fragassi, L. Chiacchio, A. M. Falanga, C. Cocchiaro, and D. Grossi. "Verbal and Spatial Memory Span in Patients with Extrapyramidal Diseases." Perceptual and Motor Skills 65, no. 2 (1987): 555–58. http://dx.doi.org/10.2466/pms.1987.65.2.555.
Full textKonagaya, M., Y. Konagaya, and M. Iida. "Clinical and magnetic resonance imaging study of extrapyramidal symptoms in multiple system atrophy." Journal of Neurology, Neurosurgery & Psychiatry 57, no. 12 (1994): 1528–31. http://dx.doi.org/10.1136/jnnp.57.12.1528.
Full textBRODAL, ALF. "SOME DATA AND PERSPECTIVES ON THE ANATOMY OF THE SO-CALLED “EXTRAPYRAMIDAL SYSTEM”." Acta Neurologica Scandinavica 39, S4 (2009): 17–38. http://dx.doi.org/10.1111/j.1600-0404.1963.tb01815.x.
Full textWALAAS, EVA, and OTTO WALAAS. "BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM." Acta Neurologica Scandinavica 39, S4 (2009): 84–94. http://dx.doi.org/10.1111/j.1600-0404.1963.tb01819.x.
Full textMoffett, John R., Martha Cassidy, and M. A. A. Namboodiri. "Selective distribution of N-acetylasparthlglutamate immunoreactivity in the extrapyramidal system of the rat." Brain Research 494, no. 2 (1989): 255–66. http://dx.doi.org/10.1016/0006-8993(89)90594-5.
Full textTarazi, Frank I., Osamu Shirakawa, and Carol A. Tamminga. "Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects." European Journal of Pharmacology 232, no. 1 (1993): 71–77. http://dx.doi.org/10.1016/0014-2999(93)90730-6.
Full textVaughan, J., and RJ Hardie. "The differential diagnosis of Parkinson’s disease." Reviews in Clinical Gerontology 12, no. 1 (2002): 40–51. http://dx.doi.org/10.1017/s0959259802012169.
Full textGliwa, Renata. "Speech and language disturbances in a patient with the clinical features of Steele‑Richardson‑Olszewski syndrome." Logopaedica Lodziensia, no. 1 (December 30, 2017): 43–61. http://dx.doi.org/10.18778/2544-7238.01.05.
Full textDorszewska, Jolanta. "Editorial (Thematic Issue: Genetics of Parkinson's Disease and Other Diseases of the Extrapyramidal System)." Current Genomics 15, no. 1 (2014): 1. http://dx.doi.org/10.2174/138920291501140306110937.
Full textLee, Henry J., David B. Rye, Ann E. Hallanger, Allan I. Levey, and Bruce H. Wainer. "Cholinergic vs. noncholinergic efferents from the mesopontine tegmentum to the extrapyramidal motor system nuclei." Journal of Comparative Neurology 275, no. 4 (1988): 469–92. http://dx.doi.org/10.1002/cne.902750402.
Full textRoizin, L., L. Cote, Y. Stern, J. C. Liu, and J. Meyers. "CORRELATED NEUROPATHOLOGICAL AND BIOCHEMICAL STUDIES OF EXTRAPYRAMIDAL SYSTEM IN THE MPTP RHESUS MONKEY PARKINSONISM." Journal of Neuropathology and Experimental Neurology 45, no. 3 (1986): 360. http://dx.doi.org/10.1097/00005072-198605000-00137.
Full text